QQ客服 官方微博 反馈留言

	Bushenjianpi formula combined with entecavir for HBeAgnegative chronic hepatitis B patients: A multicenter, randomised, double-blind, placebo-controlled trial
	Gao Y.-Q., Sun X.-H., Zhou Z.-H., Zhu X.-J., Li M., Zhang X.
刊名	Hepatology International
	2017
卷号	11
ISSN号	1936-0533
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3642092
专题	上海中医药大学
推荐引用方式 GB/T 7714	Gao Y.-Q., Sun X.-H., Zhou Z.-H., Zhu X.-J., Li M., Zhang X.. Bushenjianpi formula combined with entecavir for HBeAgnegative chronic hepatitis B patients: A multicenter, randomised, double-blind, placebo-controlled trial[J]. Hepatology International,2017,11.
APA	Gao Y.-Q., Sun X.-H., Zhou Z.-H., Zhu X.-J., Li M., Zhang X..(2017).Bushenjianpi formula combined with entecavir for HBeAgnegative chronic hepatitis B patients: A multicenter, randomised, double-blind, placebo-controlled trial.Hepatology International,11.
MLA	Gao Y.-Q., Sun X.-H., Zhou Z.-H., Zhu X.-J., Li M., Zhang X.."Bushenjianpi formula combined with entecavir for HBeAgnegative chronic hepatitis B patients: A multicenter, randomised, double-blind, placebo-controlled trial".Hepatology International 11(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。